查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2064491

被動式溫控包裝：市場佔有率分析、產業趨勢與統計、成長預測（2026-2031）

Passive Temperature Controlled Packaging - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026 - 2031)
出版日期: | 出版商: Mordor Intelligence | 英文 157 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

根據 Mordor Intelligence 預測，被動式溫控包裝市場規模將從 2025 年的 96.2 億美元和 2026 年的 105.2 億美元成長到 2031 年的 157.5 億美元，2026 年至 2031 年的複合年成長率為 8.41%。

被動式溫控封裝市場-IMG1

本報告按產品類型（保溫運輸箱、保溫容器、其他）、材料類型（塑膠、紙/紙板、其他）、用途（一次性、可重複使用）、溫度範圍（常溫、冷凍、其他）、終端用戶行業（製藥和生物技術、化學、其他）以及地區進行細分。市場預測以美元計價。

全球被動式溫控包裝市場趨勢與洞察

生物製藥和特殊藥物出貨量增加

生物製藥出貨量的成長正在改變被動式溫控包裝市場的運輸組成。許多新治療方法對熱暴露和意外冷凍都非常敏感，因此2 度C至8 度C的溫度範圍仍然是包裝設計和運輸路線合格的核心。類似的趨勢也提升了針對特定運輸路線的驗證的重要性，因為生物製藥在運輸過程中需要比傳統小分子藥物更嚴格的控制。 Cencora在2025年11月指出，到2027年，計畫在全球上市的藥物中約有50%需要低溫運輸儲存，高於十年前的37%。這顯示整個藥物研發流程對低溫運輸的依賴性正在迅速增強。隨著這些產品擴大透過專業分銷和直接分發管道流通，被動式溫控包裝市場受益於週期性出貨量的增加和包裝要求的重複性提高。這有利於那些能夠提供檢驗的負載保護能力、多種溫度保持時間選擇以及支援在季節性變化條件下進行合格的文件的供應商。

增加 GLP-1 的分發量，並將冷藏小包裹直接送達患者。

GLP-1療法正在市場上催生對小包裹式被動溫控包裝的巨大需求。這些產品非常適合專科藥局、遠端醫療通路以及依賴宅配的配送模式，凸顯了對緊湊型保溫包裝而非托盤系統的必要性。北歐冷鏈解決方案公司於2026年3月推出了GLP-1及小型包裝創新實驗室，顯示供應商如今已將此視為一項獨特的包裝挑戰，需要開發自身檢驗的配置方案。 2025年，TemperPack報告稱，美國每分鐘有12個用於運輸GLP-1的發泡聚苯乙烯保溫箱最終被掩埋。這凸顯了為何該療法類別也引發了關於低溫運輸「最後一公里」永續性的討論。如此頻繁的運輸，加上日益成長的廢棄物可見性，正促使買家重新評估其包裝尺寸和隔熱材料選擇。此外，這也增加了被動式溫控包裝市場對標準化、易於包裝的運輸包裝形式的依賴，這些處方箋形式可以隨著處方量的增加而擴展。

比較長途和高度多變配送路線上的有限停留時間和主動系統。

被動式溫控包裝市場的一大限制是保溫時間。雖然被動式溫控包裝在許多區域性和單段國際航線上都能有效發揮作用，但一旦遇到海關延誤、錯過轉機或中轉站長時間延誤等情況，其可靠性就會降低。 Peli BioThermal公司在2025年指出，高性能被動式溫控包裝可提供96至168小時的保溫保護。雖然這足以滿足許多應用場景的需求，但與主動式系統相比，其保溫時間仍然有限。當航線跨越不同的氣候帶時，這項限制會更加突出，因為同一貨物可能需要針對每個季節的高溫和低溫情況進行單獨檢驗。這降低了在多站點全球網路中運作且沿途缺乏可靠調整點的托運人的柔軟性。因此，儘管被動式溫控包裝市場在中短程航線上依然強勁，但在要求最為苛刻的洲際運輸中，主動式或混合式溫控包裝預計將繼續發揮重要作用。

細分市場分析

到2025年，保溫包裝將佔據被動式溫控包裝市場46.65%的佔有率，成為該市場最大的產品類型。其主導地位源自於其對小包裹大小的醫療用品和電商食品訂單的高度適用性，在這些領域，包裝的便利性和廣泛的溫度相容性比超大的承載能力更為重要。該產品尤其適用於直接送達患者的配送項目，因為它能夠處理小負載容量，包裝標準化，並且在配送中心能夠快速處理。 Cencora公司已宣布計劃在2030年投資10億美元，用於擴展和升級其美國配送網路。這包括在其位於阿拉巴馬州的專業設施中增建大規模冷藏庫和冷凍倉庫，從而加強支撐小包裹和專業低溫運輸運輸成長的物流基礎設施。隨著物流網路冷藏和專業處理能力的增強，保溫運輸箱憑藉其在輕鬆處理大批量貨物方面的優勢，仍然是許多常規配送項目的實用選擇。

保溫容器對於大量藥品運輸和大規模低溫運輸運輸仍然至關重要，尤其是在需要與貨物價值相符的更強大的包裝系統以及更嚴格控制的重複使用週期的情況下。雖然保溫內襯和保溫罩的市場佔有率仍然最小，但被動式溫控包裝行業正日益將它們視為可管理的資產，而非低價值的配件，從而增強運輸路線的柔軟性。 2025年10月，CSafe推出了Silverskin RE，這是一款可重複使用的保溫托盤罩，具備生命週期管理、整合追蹤功能，溫度範圍為2°C–8°C和15°C–25°C。這表明該細分市場正變得越來越注重服務。預計到2031年，冷媒和冷卻劑市場將以9.26%的複合年成長率成長，這一成長速度反映出市場正從基礎凝膠包向相變材料（PCM）形式的廣泛轉變，後者俱有更優異的熱穩定性，並為受監管的運輸路線提供高度可重複的記錄功能。與冷媒相關的被動式溫控包裝市場佔有率也受益於每次出貨物料清單 (BOM) 成本的增加。這是因為更複雜的生技藥品和 GLP-1 產品的包裝越來越需要精心客製化的冷卻劑配置，而不是通用冷卻劑。

預計到2025年，塑膠將佔被動式溫控包裝市場41.58%的佔有率，這反映了發泡聚苯乙烯（EPS）和聚氨酯在藥品和食品運輸領域長期應用。這些材料之所以能保持其市場地位，是因為它們為包裝商所熟知，供應廣泛，並且已應用於許多檢驗的包裝方案中。 EPS仍然是小包裹運輸的常用材料，因為它在許多標準冷藏運輸路線中仍能有效地平衡保溫性能和成本。聚氨酯在高規格系統中也發揮著至關重要的作用，因為這些系統必須滿足更嚴苛的運輸條件，其結構和隔熱性能必須達到更高標準。因此，即使客戶偏好開始轉變，塑膠材質仍擁有龐大的應用群體。

受永續性壓力和性能驗證技術進步的推動，生物基隔熱材料預計到2031年將以9.18%的複合年成長率成長。據TemperPack公司稱，其GreenCell泡沫平台支援60多種預先認證的運輸容器，溫度範圍涵蓋2 度C-8 度C、15 度C-25 度C C以及最高20 度C，這表明買家不再將可堆肥隔熱材料視為僅限於輕型應用的利基選擇。 Landpack公司也在推廣基於天然纖維材料的預認證生命科學冷卻解決方案，這表明生物基替代品的應用範圍正在從食品配送擴展到受監管的歐洲應用領域。因此，在被動式溫控包裝市場的中低性能領域，正在逐步進行替代，買家希望在不影響認證可靠性的前提下減少對發泡聚苯乙烯（EPS）的依賴。這項轉變仍具有選擇性。這是因為，要獲得買方的批准，新材料必須滿足與現有隔熱材料相同的運輸性能要求。

區域分析

截至2025年，北美將佔據被動式溫控包裝市場41.38%的佔有率，成為該市場的領頭羊。美國之所以能取得如此龐大的市場佔有率，主要得益於其密集的藥品分銷體系、活性化的直接送藥服務以及大規模的低溫運輸電商基礎設施。 Cencora於2025年11月宣布計劃在2030年投資10億美元用於其美國分銷網路（包括大幅擴建阿拉巴馬州的冷藏和冷凍設施），這表明該公司將繼續推進基礎設施建設，以支持藥品低溫運輸分銷。這項投資將有助於改善被動式溫控解決方案的實際情況，例如提供冷藏倉庫、提升處理能力以及建立標準化的專業分銷路線。此外，該地區廣泛採用小包裹式醫療產品配送方式，因此對保溫運輸容器、認證冷媒和小型解決方案的需求也十分旺盛。

預計到2031年，亞太地區將以9.25%的複合年成長率成長，成為被動式溫控包裝市場成長最快的區域市場。這一區域成長與製藥業的擴張、低溫運輸物流的改進以及食品電商在多個大規模消費市場的日益普及密切相關。澳洲和紐西蘭是小包裹式低溫運輸模式的早期採用者，而中國和印度龐大的製造和出口基地則推動了區域包裝需求。北歐冷鏈解決方案公司專注於GLP-1和小型化創新，其意義不僅限於北美，因為類似的小包裹式治療模式正在推廣到其他先進的醫療保健系統。這使得亞太地區的成長呈現出均衡的態勢，醫療和食品需求共同驅動，而非單一產業的擴張週期。

2025年，歐洲仍將是被動式溫控包裝市場的主要收入來源。這得歸功於德國、英國、法國、義大利和西班牙等國製藥生產的集中，以及當地嚴格的物流標準。 Landpack的預認證生命科學解決方案以及歐洲天然纖維隔熱材料的廣泛應用表明，除了溫度性能之外，永續性法規也開始影響商業包裝的選擇。儘管南美市場仍在發展中，但Peli BioThermal與巴西Polar集團於2026年3月建立的經銷合作夥伴關係表明，供應商的參與度正在提高，以擴大該地區的藥品低溫運輸。中東和非洲仍處於起步階段，但隨著醫療物流網路日益標準化和合規化，沿岸地區的交通樞紐、土耳其、南非和奈及利亞正成為重要的應用中心。

其他福利

  • Excel格式的市場預測（ME）表
  • 3個月的分析師支持

目錄

第1章：引言

  • 研究假設和市場定義
  • 調查範圍

第2章：調查方法

第3章執行摘要

第4章 市場狀況

  • 市場概覽
  • 市場促進因素
    • 生物製藥和特殊藥物出貨量增加
    • 擴大食品電商及食材自煮包低溫運輸
    • 更嚴格的GDP、USP和食品安全合規標準
    • 向可重複使用和可回收的被動式解決方案過渡
    • 增加 GLP-1 的分發量，並將冷藏小包裹直接送達患者。
    • 針對特定通道的包裝最佳化和互聯被動包裝的採用。
  • 市場限制因素
    • 比較長途和多車道環境下有限等待時間和主動系統的差異。
    • VIP 和進階 PCM 設定高成本
    • 主要醫藥走廊以外地區逆向物流的缺口降低了再利用的經濟可行性。
    • 經認證的VIP、PCM和纖維基投入鏈的供應風險
  • 產業價值鏈分析
  • 監理情勢
  • 技術展望
  • 波特五力分析

第5章 市場規模與成長預測

  • 依產品類型
    • 保溫運輸箱
    • 保溫容器
    • 冷媒和冷卻劑
    • 隔熱襯裡和蓋板
  • 依材料類型
    • 塑膠
      • 聚苯乙烯
      • 聚氨酯
      • 聚丙烯
    • 紙張和紙板
    • 生物基隔熱材料
  • 使用性別
    • 一次性的
    • 可重複使用的
  • 按溫度範圍
    • 室溫
    • 冷藏/冷藏
    • 冷凍
  • 按最終用戶行業分類
    • 製藥和生物技術
    • 飲食
    • 化學
    • 其他
  • 按地區
    • 北美洲
      • 美國
      • 加拿大
      • 墨西哥
    • 南美洲
      • 巴西
      • 阿根廷
      • 其他南美國家
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 義大利
      • 西班牙
      • 俄羅斯
      • 其他歐洲國家
    • 亞太地區
      • 中國
      • 日本
      • 韓國
      • 印度
      • 澳洲和紐西蘭
      • 其他亞太國家
    • 中東和非洲
      • 中東
        • 沙烏地阿拉伯
        • 阿拉伯聯合大公國
        • 土耳其
        • 其他中東國家
      • 非洲
        • 南非
        • 奈及利亞
        • 其他非洲地區

第6章 競爭情勢

  • 市場集中度
  • 策略趨勢
  • 市佔率分析
  • 公司簡介
    • Cold Chain Technologies, LLC
    • Pelican BioThermal LLC
    • CSafe Global Cooperatief UA
    • Softbox Systems Limited
    • va-Q-tec Thermal Solutions GmbH
    • Envirotainer AB
    • DGP Intelsius Ltd
    • Cryopak Industries Inc.
    • Inmark, LLC
    • Tempack Packaging Solutions, SL
    • Temperpack Technologies, Inc.
    • Temperatsure, LLC
    • Sofrigam SAS
    • Sealed Air Corporation
    • Polar Tech Industries Inc.

第7章 市場機會與未來展望

簡介目錄
Product Code: 98623

According to Mordor Intelligence, the passive temperature controlled packaging market size is projected to expand from USD 9.62 billion in 2025 and USD 10.52 billion in 2026 to USD 15.75 billion by 2031, registering a CAGR of 8.41% between 2026 and 2031.

Passive Temperature Controlled Packaging - Market - IMG1

This report is Segmented by Product Type (Insulated Shippers, Insulated Containers, and More), Material Type (Plastic, Paper and Paperboard, and More), Usability (Single-Use, and Reusable), Temperature Range (Ambient, Frozen, and More), End-User Industry (Pharmaceuticals and Biotechnology, Chemical, and More), and Geography. The Market Forecasts are Provided in Terms of Value (USD).

Global Passive Temperature Controlled Packaging Market Trends and Insights

Rising Biologics and Specialty Pharma Shipments

Rising biologics volumes are changing the shipment mix that supports the passive temperature controlled packaging market. Many newer therapies are sensitive to both heat exposure and unintended freezing, which keeps the 2°C to 8°C range central to packaging design and lane qualification. The same trend is increasing the value of route-specific validation, as biologics require tighter control than traditional small-molecule drugs during transit. Cencora stated in November 2025 that nearly 50% of drugs expected to launch globally through 2027 would require cold chain storage, up from 37% a decade earlier, which shows how quickly cold chain dependence is widening across drug pipelines. As more of these products move through specialty distribution and direct dispensing channels, the passive temperature controlled packaging market benefits from larger recurring shipment volumes and more repeatable pack-out requirements. This favors suppliers that can offer validated payload protection, multiple duration options, and documentation that supports qualification across changing seasonal conditions.

Growth In GLP-1 and Direct-To-Patient Refrigerated Parcel Flows

GLP-1 therapies are creating a large parcel-based demand stream for the passive temperature controlled packaging market. These products fit a delivery model that relies on specialty pharmacies, telehealth channels, and home delivery, underscoring the need for compact, insulated formats rather than pallet systems. Nordic Cold Chain Solutions launched a GLP-1 and small-format packaging innovation lab in March 2026, indicating that suppliers now see this as a distinct packaging problem that requires its own validated configurations. TemperPack reported in 2025 that 12 EPS foam coolers used for GLP-1 shipments were being discarded in US landfills every minute, underscoring why this therapy category is also drawing sustainability concerns into the last-mile cold chain discussion. That combination of high shipment frequency and rising waste visibility is prompting buyers to review both pack size and insulation choice simultaneously. It also makes the passive temperature controlled packaging market more dependent on standardized, easy-to-pack shipper formats that can scale with prescription volume growth.

Limited Hold Time Versus Active Systems on Long and Variable Lanes

Hold-time limits remain a practical constraint on the passive temperature controlled packaging market. Passive formats work well on many regional and single-leg international lanes, but they become harder to rely on when a shipment faces customs delays, missed connections, or long dwell time at transfer points. Peli BioThermal stated in 2025 that high-performance passive configurations can provide 96 to 168 hours of protection, which is strong for many use cases but still finite compared with active-powered systems. The constraint becomes sharper when the route spans different climates, as the same payload may require separate validation for hot and cold seasonal profiles. This reduces flexibility for shippers that operate across global multi-stop networks and lack reliable reconditioning points along the route. As a result, the passive temperature controlled packaging market is likely to remain strongest in short-to-medium-haul lanes, while the hardest intercontinental movements continue to play a larger role for active or hybrid approaches.

Other drivers and restraints analyzed in the detailed report include:

  1. Expansion of Food E-Commerce and Meal-Kit Cold Chains
  2. Tightening GDP, USP, and Food-Safety Compliance Standards
  3. High Cost of VIP and Advanced PCM Configurations

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Insulated shippers held 46.65% share in 2025, making them the largest product category in the passive temperature controlled packaging market. Their lead position comes from a strong fit with parcel-sized healthcare shipments and food e-commerce orders, where ease of packing and broad temperature coverage matter more than very large payload capacity. The product is especially well aligned with direct-to-patient programs because it supports small payloads, standardized pack-outs, and fast handling at distribution sites. Cencora announced a USD 1 billion investment through 2030 to expand and modernize its US distribution network, including major refrigerated and frozen storage additions at its Alabama specialty facility, which supports the underlying logistics infrastructure that keeps parcel and specialty cold chain traffic growing. As distribution networks add more cold storage and specialized handling capacity, insulated shippers remain the practical choice for many repeat-shipment programs because they are easy to scale across large delivery volumes.

Insulated containers remain important for bulk pharmaceutical flows and larger cold chain moves, especially where shipment value justifies a stronger packaging system and a more controlled reuse cycle. Thermal liners and covers still represent the smallest product slice, but the passive temperature controlled packaging industry is treating them less as low-value accessories and more as managed assets that can add lane flexibility. CSafe launched Silverskin RE in October 2025 as a reusable thermal pallet cover with lifecycle management, integrated tracking, and support for 2°C to 8°C and 15°C to 25°C ranges, which shows how this sub-segment is becoming more service oriented. Refrigerants and coolants are projected to grow at 9.26% CAGR through 2031, and that pace reflects the wider shift from basic gel packs toward PCM formats that offer better thermal stability and more repeatable documentation for regulated shipment lanes. The passive temperature controlled packaging market share tied to refrigerants also benefits from higher bill-of-materials content per shipment because more complex biologic and GLP-1 pack-outs often require carefully matched coolant configurations rather than a generic cold source.

Plastic accounted for 41.58% of the passive temperature controlled packaging market in 2025, reflecting the long-established use of EPS and polyurethane across pharmaceutical and food shipment formats. These materials have kept their position because they are familiar to packers, widely available, and already embedded in many validated pack-outs. EPS has remained common in parcel shipping because it balances thermal performance and cost in a way that still works for many standard cold lanes. Polyurethane also plays a role in higher-specification systems where structure and insulation value need to support more demanding transport conditions. This leaves plastic-based materials with a large installed base even as customer preferences begin to shift.

Bio-based insulation materials are projected to expand at a 9.18% CAGR through 2031, driven by a mix of sustainability pressures and improving proof of performance. TemperPack said its GreenCell Foam platform supports more than 60 pre-qualified shippers across 2°C to 8°C, 15°C to 25°C, and -20°C temperature profiles, indicating that buyers no longer see compostable insulation as a niche option only for light-duty applications. Landpack also promotes pre-qualified life science cooling solutions based on natural fiber materials, indicating that bio-based alternatives are moving into regulated use cases in Europe rather than remaining limited to food delivery. The passive temperature controlled packaging market is therefore seeing a gradual replacement path at the low-to-mid performance tier, where buyers want to reduce reliance on EPS without losing qualification confidence. This transition remains selective because the material must meet the same transit expectations as incumbent insulation before the buyer will approve a switch.

Geography Analysis

North America held a 41.38% share in 2025, making it the leading region in the passive temperature controlled packaging market. The United States drives most of that scale by combining a dense pharmaceutical distribution system with strong direct-to-patient shipments and a large cold-chain e-commerce base. Cencora's November 2025 plan to invest USD 1 billion through 2030 in its US distribution network, including major refrigerated and frozen expansion in Alabama, points to continued infrastructure build-out behind pharmaceutical cold chain flows. That investment supports the practical conditions that help passive solutions scale, including access to cold storage, handling capacity, and standardized specialty distribution lanes. The region also benefits from strong adoption of parcel-format healthcare shipping, which keeps demand high for insulated shippers, qualified refrigerants, and small-format solutions.

Asia-Pacific is projected to grow at a 9.25% CAGR through 2031, making it the fastest-growing regional segment in the passive temperature controlled packaging market. The region's growth is tied to expanding pharmaceutical manufacturing, improving cold chain logistics, and stronger food e-commerce penetration across several large consumer markets. Australia and New Zealand are important early adopters in parcel cold chain formats, while China and India support the broad manufacturing and export base that is raising regional packaging needs. Nordic Cold Chain Solutions' focus on GLP-1 and small-format innovation also has relevance beyond North America because the same parcel-based therapy model is spreading into other developed healthcare systems. This leaves Asia-Pacific with both healthcare and food demand drivers, which gives the regional growth story more balance than a single-sector expansion cycle.

Europe remained a major revenue base for the passive temperature controlled packaging market in 2025, supported by pharmaceutical manufacturing density and regulated logistics standards across Germany, the United Kingdom, France, Italy, and Spain. Landpack's pre-qualified life science solutions and the broader move toward natural fiber insulation in Europe show how sustainability rules are starting to affect commercial packaging choice in addition to temperature performance. South America is still developing, but Peli BioThermal's March 2026 distribution partnership with Polar Group in Brazil indicates growing supplier commitment to pharmaceutical cold chain expansion in the region. The Middle East and Africa remains earlier stage, with Gulf transit hubs, Turkey, South Africa, and Nigeria forming the main points of adoption as healthcare logistics networks become more structured and more compliance driven.

  1. Cold Chain Technologies, LLC
  2. Pelican BioThermal LLC
  3. CSafe Global Cooperatief U.A.
  4. Softbox Systems Limited
  5. va-Q-tec Thermal Solutions GmbH
  6. Envirotainer AB
  7. DGP Intelsius Ltd
  8. Cryopak Industries Inc.
  9. Inmark, LLC
  10. Tempack Packaging Solutions, S.L.
  11. Temperpack Technologies, Inc.
  12. Temperatsure, LLC
  13. Sofrigam SAS
  14. Sealed Air Corporation
  15. Polar Tech Industries Inc.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET LANDSCAPE

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Biologics and Specialty Pharma Shipments
    • 4.2.2 Expansion of Food E-Commerce and Meal-Kit Cold Chains
    • 4.2.3 Tightening GDP, USP, and Food-Safety Compliance Standards
    • 4.2.4 Shift Toward Reusable and Recyclable Passive Solutions
    • 4.2.5 Growth in GLP-1 and Direct-to-Patient Refrigerated Parcel Flows
    • 4.2.6 Adoption of Lane-Specific Pack-Out Optimization and Connected Passive Packaging
  • 4.3 Market Restraints
    • 4.3.1 Limited Hold Time Versus Active Systems on Long and Variable Lanes
    • 4.3.2 High Cost of VIP and Advanced PCM Configurations
    • 4.3.3 Reverse-Logistics Gaps Reducing Reuse Economics Outside Core Pharma Corridors
    • 4.3.4 Supply Risk in Qualified VIP, PCM, and Fiber-Based Input Chains
  • 4.4 Industry Value Chain Analysis
  • 4.5 Regulatory Landscape
  • 4.6 Technological Outlook
  • 4.7 Porter's Five Forces Analysis
    • 4.7.1 Threat of New Entrants
    • 4.7.2 Bargaining Power of Suppliers
    • 4.7.3 Bargaining Power of Buyers
    • 4.7.4 Threat of Substitutes
    • 4.7.5 Competitive Rivalry

5 MARKET SIZE AND GROWTH FORECASTS (VALUE)

  • 5.1 By Product Type
    • 5.1.1 Insulated Shippers
    • 5.1.2 Insulated Containers
    • 5.1.3 Refrigerants and Coolants
    • 5.1.4 Thermal Liners and Covers
  • 5.2 By Material Type
    • 5.2.1 Plastic
      • 5.2.1.1 Polystyrene
      • 5.2.1.2 Polyurethane
      • 5.2.1.3 Polypropylene
    • 5.2.2 Paper and Paperboard
    • 5.2.3 Bio-Based Insulation Materials
  • 5.3 By Usability
    • 5.3.1 Single-Use
    • 5.3.2 Reusable
  • 5.4 By Temperature Range
    • 5.4.1 Ambient
    • 5.4.2 Chilled/Refrigerated
    • 5.4.3 Frozen
  • 5.5 By End-User Industry
    • 5.5.1 Pharmaceuticals and Biotechnology
    • 5.5.2 Food and Beverage
    • 5.5.3 Chemical
    • 5.5.4 Other End-Use Industries
  • 5.6 By Geography
    • 5.6.1 North America
      • 5.6.1.1 United States
      • 5.6.1.2 Canada
      • 5.6.1.3 Mexico
    • 5.6.2 South America
      • 5.6.2.1 Brazil
      • 5.6.2.2 Argentina
      • 5.6.2.3 Rest of South America
    • 5.6.3 Europe
      • 5.6.3.1 Germany
      • 5.6.3.2 United Kingdom
      • 5.6.3.3 France
      • 5.6.3.4 Italy
      • 5.6.3.5 Spain
      • 5.6.3.6 Russia
      • 5.6.3.7 Rest of Europe
    • 5.6.4 Asia-Pacific
      • 5.6.4.1 China
      • 5.6.4.2 Japan
      • 5.6.4.3 South Korea
      • 5.6.4.4 India
      • 5.6.4.5 Australia and New Zealand
      • 5.6.4.6 Rest of Asia-Pacific
    • 5.6.5 Middle East and Africa
      • 5.6.5.1 Middle East
        • 5.6.5.1.1 Saudi Arabia
        • 5.6.5.1.2 United Arab Emirates
        • 5.6.5.1.3 Turkey
        • 5.6.5.1.4 Rest of Middle East
      • 5.6.5.2 Africa
        • 5.6.5.2.1 South Africa
        • 5.6.5.2.2 Nigeria
        • 5.6.5.2.3 Rest of Africa

6 COMPETITIVE LANDSCAPE

  • 6.1 Market Concentration
  • 6.2 Strategic Moves
  • 6.3 Market Share Analysis
  • 6.4 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products and Services, and Recent Developments)
    • 6.4.1 Cold Chain Technologies, LLC
    • 6.4.2 Pelican BioThermal LLC
    • 6.4.3 CSafe Global Cooperatief U.A.
    • 6.4.4 Softbox Systems Limited
    • 6.4.5 va-Q-tec Thermal Solutions GmbH
    • 6.4.6 Envirotainer AB
    • 6.4.7 DGP Intelsius Ltd
    • 6.4.8 Cryopak Industries Inc.
    • 6.4.9 Inmark, LLC
    • 6.4.10 Tempack Packaging Solutions, S.L.
    • 6.4.11 Temperpack Technologies, Inc.
    • 6.4.12 Temperatsure, LLC
    • 6.4.13 Sofrigam SAS
    • 6.4.14 Sealed Air Corporation
    • 6.4.15 Polar Tech Industries Inc.

7 MARKET OPPORTUNITIES AND FUTURE OUTLOOK

  • 7.1 White-Space and Unmet-Need Assessment